Investigating the effects of vaping nicotine and cannabis in young people
Vaping Nicotine and Cannabis Across Adolescence and Young Adulthood
This study is looking at how vaping nicotine and cannabis impacts young people aged 12 to 20, to see if it leads to more smoking or if it’s linked to other challenges they might be facing, with the goal of helping to create better health strategies for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10926856 on NIH RePORTER |
What this research studies
This research explores how vaping nicotine and cannabis affects adolescents and young adults, particularly those aged 12 to 20. It aims to understand whether vaping leads to increased smoking or reflects existing behavioral issues among high-risk youth. The study will examine various vaping products and their potential addictive qualities, as well as the social and psychological factors that influence vaping behaviors. By gathering data on these aspects, the research seeks to inform public health strategies and prevention efforts.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults aged 12 to 20 who are currently using or have used vaping products.
Not a fit: Patients who are not within the age range of 12 to 20 or who do not engage in vaping may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention strategies for vaping and smoking among young people.
How similar studies have performed: Previous research has indicated concerns about vaping among adolescents, but this specific approach using the catalyst model is relatively novel.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Leventhal, Adam Matthew — University of Southern California
- Study coordinator: Leventhal, Adam Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.